It's safe to assume at this point that the next generation of Apple Watches might not look dramatically different on the outside, but a fresh rumour suggests one of the wearable’s most controversial ...

WASHINGTON – Danaher Corporation, a global science and technology company, has entered into a definitive agreement to acquire Masimo Corporation, a specialty diagnostics provider of pulse oximetry and ...

An announcement from Masimo ( (MASI)) is now available. On May 1, 2026, Masimo shareholders approved the company’s merger agreement with Danaher Corporation at a virtual special meeting, with roughly ...

Abstract: The objective of this work is to implement and test an innovative single-unit multi-PPG measurement system to assess pulse transit time (PTT) measured between two sites on the forearm as a ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to ...

Masimo Corporation (Nasdaq: MASI) ("Masimo"), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced ...

Masimo’s NeoPODS study in critically ill newborns found its SET pulse oximetry technology delivered consistent accuracy across all skin tones, with less than 1% bias. The findings address longstanding ...

Masimo MASI recently reported findings from the NeoPODS study, a large prospective real-world evaluation of its SET pulse oximetry technology in critically ill newborns. The study demonstrated less ...

This review synthesised existing evidence on racial disparities in pulse oximeter accuracy, quantified the degree of bias, evaluated clinical effects, highlighted implications for practice, and ...

A NICU study evaluating Masimo SET® pulse oximetry on hospitalized newborns found no clinically significant differences in ...

Masimo (NASDAQ: MASI) today announced the findings of a study evaluating the accuracy of Masimo SET ® pulse oximetry among critically ill neonates and demonstrating less than 1% overall statistical ...